Literature DB >> 14529662

Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.

V M Berlin Grace1, J Veronica Shalini, T T Sree lekha, S Niranjali Devaraj, Halagowder Devaraj.   

Abstract

OBJECTIVE: The aim of this study was to analyze aberrant expression of both apoptotic protein p53 and antiapoptotic protein bcl-2 in squamous cell carcinoma (SCC) of the uterine cervix with HPV infection and its significance as a marker for progression of cervical lesions.
METHODS: One hundred and five cervical lesions and 20 normal (age matched) cervical epithelium from patients with complaints other than cervical lesions were investigated immunocytochemically for aberrant expression of p53 and bcl-2 using the streptavidin-biotin-peroxidase method with respective monoclonal antibodies. HPV status was also anlayzed using type-specific primers for HPV 16/18 and HPV 6/11 by polymerase chain reaction (PCR). The statistical correlation analysis was carried out using Spearman's correlation test and univariate analysis by the SPSS system.
RESULTS: An abnormal nuclear expression of tumor-suppressor protein p53 and cytoplasmic expression of bcl-2 were observed using immunocytochemistry in biopsies of cervical lesions but not in normal subjects. The intensity of immunoreactivity for both p53 and bcl-2 proteins varied between different histopathological grades of cervical lesions and the correlation analysis showed a highly significant positive correlation for their expression level with different stages from mild dysplasia to invasive cancer with r = 0.88842; P = 0.00001 and r = 0.86929; P = 0.00001, respectively. A highly significant positive correlation was also observed between the expression of both p53 and bcl-2 proteins and HPV infection. The current study indicates a very good significant direct correlation (r = 0.83925; P = 0.00001) between p53 expression and bcl-2 expression in the study population, suggesting the co-overexpression of these proteins in HPV-associated cervical cancer.
CONCLUSIONS: From the observations it is suggested that the immunodetection of both p53 and bcl-2 proteins in squamous cell carcinoma of the uterine cervix can be used as an independent diagnostic marker for cervical cancer associated with HPV infection. The highly significant association of these proteins with HPV infection suggests that the high-risk HPV infection may be responsible for the co-overexpression of p53 and bcl-2 in cervical cancer even though both of them are antagonistic in their function. This study thus helps to understand the molecular mechanism underlying cervical carcinogenesis and which in turn may improve the therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14529662     DOI: 10.1016/s0090-8258(03)00439-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.

Authors:  Eduardo Cambruzzi; Cláudio Galleano Zettler; Cláudio Osmar Pereira Alexandre
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Immunohistochemical expression of apoptosis regulators in squamous cell carcinoma of the cervix and their association with human papillomavirus 16/18 subtypes.

Authors:  Hossein Ayatollahi; Nourieh Sharifi; Mohammad Hadi Sadeghian; Anita Alenabi; Hamid Reza Ghasemian-Moghadam
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

3.  Expression of p14(ARF), p15(INK4b), p16(INK4a) and skp2 increases during esophageal squamous cell cancer progression.

Authors:  Peng Bai; Xue Xiao; Juan Zou; Lin Cui; Tri M Bui Nguyen; Jinsong Liu; Jianguo Xiao; Bin Chang; Jin Wu; He Wang
Journal:  Exp Ther Med       Date:  2012-03-22       Impact factor: 2.447

4.  Differential expression of anti-apoptotic protein Bcl-2 in keratinizing versus non-keratinizing squamous cell carcinoma of the anus.

Authors:  Abdelkarim S Allal; Marie-Anne Bründler; Pascal Gervaz
Journal:  Int J Colorectal Dis       Date:  2004-10-02       Impact factor: 2.571

5.  bcl-2 and p53 as novel biomarkers for predicting malignant transformation in chronic osteomyelitis.

Authors:  Hans Kristian Nugraha; I Gede Eka Wiratnaya; Putu Astawa; I Wayan Juli Sumadi
Journal:  Musculoskelet Surg       Date:  2022-01-07

6.  The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma.

Authors:  Qian He; Shu-Qun Zhang; Yong-Lie Chu; Xiao-Li Jia; Xiang-Ling Wang
Journal:  Mol Biol Rep       Date:  2008-04-22       Impact factor: 2.316

7.  Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas.

Authors:  Florentina Bocaneti; Gennaro Altamura; Annunziata Corteggio; Elena Velescu; Giuseppe Borzacchiello
Journal:  Infect Agent Cancer       Date:  2015-01-12       Impact factor: 2.965

8.  Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.

Authors:  Xue Xiao; Gong Yang; Peng Bai; Shunping Gui; Tri M Bui Nyuyen; Imelda Mercado-Uribe; Mei Yang; Juan Zou; Qintong Li; Jianguo Xiao; Bin Chang; Guangzhi Liu; He Wang; Jinsong Liu
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

9.  p53 and bcl2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18.

Authors:  Shailaja Shukla; Jasmita Dass; Mukta Pujani
Journal:  South Asian J Cancer       Date:  2014-01

10.  Synergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell lines.

Authors:  Benedict Shi Xiang Lian; Angeline En Hui Yek; Hemalata Shuvas; Siti Fairus Abdul Rahman; Kalaivani Muniandy; Nethia Mohana-Kumaran
Journal:  BMC Res Notes       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.